Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Abbott
Innovative Diagnostic Instrument Introduced by Abbott for Low- to Mid-Volume Laboratory Market Segment
May 4th, 2008
Abbott (NYSE:ABT) has introduced the ARCHITECT(R) i1000SR(R) immunochemistry analyzer, expanding its ARCHITECT family of diagnostics instrument systems for clinical laboratories. Designed for labs that typically perform less than 200 immunoassay tests per day, the instrument addresses many of the workflow challenges common in today's laboratories. With the increased demand for diagnostic testing, laboratories, both large and small, need to process tests as quickly and efficiently as possible. By providing continuous access to reagents and samples while the instrument is running, the ARCHITECT i1000SR enhances laboratory productivity. Additionally, a wide test menu,...
Source: Pharma Investments, Ventures & Law Weekly (2008-05-04)
|
